| Incidence of pregnancy and disease-modifying therapy exposure trends in women with multiple sclerosis: a contemporary cohort study AL Nguyen, EK Havrdova, D Horakova, G Izquierdo, T Kalincik, ... Multiple sclerosis and related disorders 28, 235-243, 2019 | 49 | 2019 |
| Pregnancy and multiple sclerosis: clinical effects across the lifespan AL Nguyen, A Eastaugh, A van der Walt, VG Jokubaitis Autoimmunity reviews 18 (10), 102360, 2019 | 34 | 2019 |
| Family planning, antenatal and post partum care in multiple sclerosis: a review and update A Van Der Walt, AL Nguyen, V Jokubaitis Medical Journal of Australia 211 (5), 230-236, 2019 | 27 | 2019 |
| Predicting infection risk in multiple sclerosis patients treated with Ocrelizumab: a retrospective cohort study N Seery, S Sharmin, V Li, AL Nguyen, C Meaton, R Atvars, N Taylor, ... CNS drugs 35, 907-918, 2021 | 25 | 2021 |
| Association of pregnancy with the onset of clinically isolated syndrome AL Nguyen, K Vodehnalova, T Kalincik, A Signori, EK Havrdova, ... JAMA neurology 77 (12), 1496-1503, 2020 | 24 | 2020 |
| Monoclonal antibodies in the treatment of multiple sclerosis: emergence of B‐cell‐targeted therapies AL Nguyen, M Gresle, T Marshall, H Butzkueven, J Field British journal of pharmacology 174 (13), 1895-1907, 2017 | 24 | 2017 |
| Comparative effectiveness of autologous hematopoietic stem cell transplant vs fingolimod, natalizumab, and ocrelizumab in highly active relapsing-remitting multiple sclerosis T Kalincik, S Sharmin, I Roos, MS Freedman, H Atkins, J Burman, ... JAMA neurology 80 (7), 702-713, 2023 | 15 | 2023 |
| Fast and safe: optimising multiple sclerosis infusions during COVID-19 pandemic L Rath, MV Bui, J Ellis, J Carey, J Baker, L Taylor, H Fernando, N Taylor, ... Multiple Sclerosis and Related Disorders 47, 102642, 2021 | 12 | 2021 |
| Rituximab vs ocrelizumab in relapsing-remitting multiple sclerosis I Roos, S Hughes, G McDonnell, CB Malpas, S Sharmin, C Boz, ... JAMA neurology 80 (8), 789-797, 2023 | 11 | 2023 |
| Validation of a precision tremor measurement system for multiple sclerosis T Perera, WL Lee, SAC Yohanandan, AL Nguyen, B Cruse, ... Journal of Neuroscience Methods 311, 377-384, 2019 | 10 | 2019 |
| Evaluating the perspective of patients with MS and related conditions on their DMT in relation to the COVID-19 pandemic in one MS centre in Australia N Seery, V Li, AL Nguyen, I Roos, KA Buzzard, R Atvars, N Taylor, ... Multiple Sclerosis and Related Disorders 46, 102516, 2020 | 8 | 2020 |
| Long-Term Stability of Neuroaxonal Structure in Alemtuzumab-Treated Relapsing–Remitting Multiple Sclerosis Patients JK Chan, EHM de Lapiscina, C Taylor, AL Nguyen, S Alba-Arbalat, ... Journal of Neuro-Ophthalmology 40 (1), 37-43, 2020 | 8 | 2020 |
| Impact of telehealth on health care in a multiple sclerosis outpatient clinic during the COVID-19 pandemic V Li, I Roos, M Monif, C Malpas, S Roberts, M Marriott, K Buzzard, ... Multiple Sclerosis and Related Disorders 63, 103913, 2022 | 7 | 2022 |
| Research in International Business and Finance Financial performances, entrepreneurial factors and coping strategy to survive in the COVID-19 pandemic?: case of Vietnam … H Huu, V Minh, A Nguyen, T Tran | 6 | 2021 |
| Prospective study of Retinal Nerve Fibre Layer Thickness in Alemtuzumab Treated Multiple Sclerosis Patients (P3. 083) AL Nguyen, J Lam, R White, R Carruthers, A Traboulsee Neurology 86 (16_supplement), P3. 083, 2016 | 5 | 2016 |
| Disability accrual in primary and secondary progressive multiple sclerosis S Harding-Forrester, I Roos, AL Nguyen, CB Malpas, I Diouf, N Moradi, ... Journal of Neurology, Neurosurgery & Psychiatry 94 (9), 707-717, 2023 | 3 | 2023 |
| Risk of Cervical Abnormalities for Women With Multiple Sclerosis Treated With Moderate-Efficacy and High-Efficacy Disease-Modifying Therapies F Bridge, J Brotherton, J Stankovich, PG Sanfilippo, OG Skibina, ... Neurology 102 (4), e208059, 2024 | 1 | 2024 |
| Assessing the reliability of longitudinal MRI examinations in multiple sclerosis follow-up DM Sima, D Horáková, AL Nguyen, W Van Hecke, T Kalincik, MH Barnett, ... MULTIPLE SCLEROSIS JOURNAL 25, 253-254, 2019 | 1 | 2019 |
| 020 Increased risk of an abnormal cervical screening test in women with MS exposed to high-efficacy disease-modifying treatments A Van der Walt, J Yuvaraj, J Stankovich, N McGuinn, L Rath, O Skibina, ... Journal of Neurology, Neurosurgery & Psychiatry 90 (e7), A7-A7, 2019 | 1 | 2019 |
| Durable neuroprotective effects of alemtuzumab over 5 years on retinal nerve fibre layer and ganglion cell layers in relapsing-remitting multiple sclerosis (RRMS) patients JK Chan, C Taylor, A Traboulsee, AL Nguyen, EH Martinez-Lapiscina, ... MULTIPLE SCLEROSIS JOURNAL 23, 562-563, 2017 | 1 | 2017 |
